Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs (Q41922000)

14 October 2017

title

Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs (English)

1 reference

14 October 2017

1 reference

Vezmar M

1

1 reference

14 October 2017

Georges E

series ordinal

2

1 reference

14 October 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

14 October 2017

published in

Biochemical Pharmacology

1 reference

14 October 2017

volume

59

1 reference

14 October 2017

issue

10

1 reference

14 October 2017

page(s)

1245-1252

1 reference

The biochemistry of P-glycoprotein-mediated multidrug resistance

14 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Biochemistry of multidrug resistance mediated by the multidrug transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Reconstitution of Drug Transport by Purified P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Role of multidrug resistance P-glycoproteins in cholesterol biosynthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

ABC Transporters: From Microorganisms to Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Isolation and expression of a complementary DNA that confers multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

ATP-dependent transport of aflatoxin B1 and its glutathione conjugates by the product of the multidrug resistance protein (MRP) gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

ATP-dependent 17 beta-estradiol 17-(beta-D-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for Neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Modulation of multidrug resistance: at the threshold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Expression of the Gene for Multidrug-Resistance–Associated Protein and Outcome in Patients with Neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

MRP gene overexpression in a human doxorubicin-resistant SCLC cell line: alterations in cellular pharmacokinetics and in pattern of cross-resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Biology of the multidrug resistance-associated protein, MRP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Decreased drug accumulation without increased drug efflux in a novel MRP-overexpressing multidrug-resistant cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Reversal by a Dihydropyridine Derivative of Non-P-Glycoprotein-Mediated Multidrug Resistance in Etoposide-Resistant Human Prostatic Cancer Cell Line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

The quinoline-based drug, N-[4-[1-hydroxy-2-(dibutylamino)ethyl] quinolin-8-yl]-4-azidosalicylamide, photoaffinity labels the multidrug resistance protein (MRP) at a biologically relevant site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Rapid and efficient purification of plasma membrane from cultured cells: characterization of epidermal growth factor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Reversal of P-glycoprotein-associated multidrug resistance by ivermectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Novel actions of inhibitors of DNA topoisomerase II in drug-resistant tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

High mdr1- and mrp-, but low topoisomerase II alpha-gene expression in B-cell chronic lymphocytic leukaemias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Reduced topoisomerase II activity in multidrug-resistant human non-small cell lung cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Reduced levels of topoisomerase II? and II? in a multidrug-resistant lung-cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Cellular and karyotypic characterization of two doxorubicin resistant cell lines isolated from the same parental human leukemia cell line.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Overexpression of a 40-kDa Protein in Human Multidrug Resistant Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Photoaffinity substrates for P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Quinoline antimalarials: mechanisms of action and resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

One-electron reduction of the antimalarial drug primaquine, studied by pulse radiolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Studies on the mechanisms of oxidation in the erythrocyte by metabolites of primaquine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Primaquine-induced oxidative stress in isolated hepatocytes as a result of reductive activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

Direct interaction between a quinoline derivative, MS-209, and multidrug resistance protein (MRP) in human gastric cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(00)00270-7

10.1016/S0006-2952(00)00270-7

7 January 2021

Identifiers

DOI

1 reference

14 October 2017

1 reference